Dr. Joseph Kim joins the OncoLens Advisory Board

Dr. Joseph Kim, President of Q Synthesis LLC, is honored to be added to the OncoLens Advisory Board! 

​OncoLens is an oncology-focused digital health platform that enhances cancer care through proprietary AI-driven analytics and multidisciplinary collaboration tools. By leveraging structured and unstructured data, OncoLens improves patient outcomes and revenue opportunities by preventing patient leakage and proactively identifying patients for clinical trials, biomarker testing or other key services. The platform's analytics tools enable both centers and industry to derive insights into patient cohorts, identify new opportunities and improve quality. The OncoLens Research Network collaborates with industry partners to bring curated research and real world evidence initiatives to cancer centers.

www.prweb.com/releases/oncolens-expands-board-with-addition-of-dr-prasanth-reddy-and-welcomes-advisory-members-dr-joseph-kim-and-dr-walter-curran-302458293.html